Using menstrual blood, the technology of Nextgen Jane can determine whether a woman has endometriosis, cervical cancer, or other potential medical issues. Women send a tampon, worn for around two hours, to the laboratory for research. Traditionally, this diagnosis is given based on a smear, an uncomfortable procedure for many women. Nextgen Jane makes it more comfortable and easier for women to have this research done, and aims to lower cervical cancer’s mortality rate. By testing many women’s tampons, the diagnosis becomes ever more accurate, and advice for follow-up steps can be given.